from bench to board

Back in August, I had written to JAMA in response to Dr. Ezekiel J. Emanuel's JAMA Letter to the Editor. In it, he claimed that support of NIH funding was dwindling because its breakthroughs have been largely exciting scientifically but not creating enough societal value. He attributes NIH research to rising medical costs and argues that NIH should only fund cost-lowering and value-creating research.